- Home
- HY vs ATYR Comparison
HY vs ATYR Comparison
Compare HY & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HY
- ATYR
- Stock Information
- Founded
- HY 1991
- ATYR 2005
- Country
- HY United States
- ATYR United States
- Employees
- HY N/A
- ATYR N/A
- Industry
- HY Construction/Ag Equipment/Trucks
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HY Industrials
- ATYR Health Care
- Exchange
- HY Nasdaq
- ATYR Nasdaq
- Market Cap
- HY 668.1M
- ATYR 535.0M
- IPO Year
- HY N/A
- ATYR 2015
- Fundamental
- Price
- HY $36.22
- ATYR $1.03
- Analyst Decision
- HY Strong Buy
- ATYR Strong Buy
- Analyst Count
- HY 1
- ATYR 5
- Target Price
- HY $70.00
- ATYR $23.25
- AVG Volume (30 Days)
- HY 77.5K
- ATYR 4.9M
- Earning Date
- HY 11-04-2025
- ATYR 11-06-2025
- Dividend Yield
- HY 4.03%
- ATYR N/A
- EPS Growth
- HY N/A
- ATYR N/A
- EPS
- HY 1.26
- ATYR N/A
- Revenue
- HY $3,950,600,000.00
- ATYR N/A
- Revenue This Year
- HY N/A
- ATYR $478.72
- Revenue Next Year
- HY $0.23
- ATYR $1,899.26
- P/E Ratio
- HY $28.37
- ATYR N/A
- Revenue Growth
- HY N/A
- ATYR N/A
- 52 Week Low
- HY $34.13
- ATYR $1.67
- 52 Week High
- HY $69.28
- ATYR $7.29
- Technical
- Relative Strength Index (RSI)
- HY 41.53
- ATYR 21.81
- Support Level
- HY $35.44
- ATYR $5.08
- Resistance Level
- HY $37.09
- ATYR $6.50
- Average True Range (ATR)
- HY 1.06
- ATYR 0.47
- MACD
- HY -0.05
- ATYR -0.25
- Stochastic Oscillator
- HY 14.30
- ATYR 0.82
About HY Hyster-Yale Materials Handling Inc.
Hyster Yale Inc designs, engineers, manufactures, sells and services a comprehensive line of lift trucks, attachments, aftermarket parts and technology solutions marketed globally under the Hyster and Yale brand names. The Company has five segments, which include three in the lift truck business as discussed below, as well as Bolzoni S.p.A. (Bolzoni) and Nuvera Fuel Cells, LLC (Nuvera). Majority of revenue is from Lift Trucks. geographically operates in America, EMEA, JAPIC, maximum revenue from America.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.